[Randomised clinical trial of an intensive intervention into life-styles of patients with hyperfibrinogenaemia in primary prevention of cardiovascular pathology in primary health care].
OBJECTIVE
To study the effect of an intensive programme to modify life-style on levels of plasma fibrinogen in patients without cardiovascular pathology, with high fibrinogen and normal cholesterol levels. To analyse whether the effect on fibrinogen is independent, or otherwise, of the effect on lipids.


METHODS
Randomised clinical trial with a control.


METHODS
11 health districts in L'Hospitalet de Llobregat and Barcelona.


METHODS
436 patients will be included, 218 individuals between 35 and 75 years old in each group, and without cardiovascular pathology (ischaemic cardiopathy, cerebral vascular accident or peripheral arteriopathy), with hyperfibrinogenaemia (fibrinogen > 300 mg/dL) and with plasma control < 250 mg/dL.


METHODS
One group of patients will receive an intensive intervention (in frequency and intensity of counselling and treatment) for life-style changes, i.e. stopping smoking, low-calorie diet in case of overweight or obesity, and physical exercise. The follow-up of the intervention group will be every 2 months. The control group will follow customary treatments.


METHODS
Levels of plasma fibrinogen. In addition, other relevant events will be recorded over a 2-year monitoring period: modification of risk factors, changes in quality of life, cardiovascular events or death.


CONCLUSIONS
The introduction of an intensive primary prevention intervention (life-style changes) in patients with hyperfibrinogenaemia could be a more effective measure than the habitual intervention for reducing plasma fibrinogen figures. In addition, these measures could be translated into a reduction of cardiovascular risk and an improvement in the patient s quality of life.
Rodríguez Cristóbal
J J
JJ
ABS Florida Sud, L'Hospitalet de Llobregat, Barcelona, España.
Benavides Márquez
F
F
Villaverde Grote
C
C
Peña Sendra
E
E
Flor Serra
F
F
Travé Mercadé
P
P
D000328:Adult; D000368:Aged; D002318:Cardiovascular Diseases / Q000097:blood / Q000209:etiology* / Q000517:prevention & control*; D020147:Coagulation Protein Disorders / Q000097:blood* / Q000150:complications*; D005260:Female; D005340:Fibrinogen / Q000032:analysis*; D006801:Humans; D008019:Life Style; D008297:Male; D008875:Middle Aged; D011320:Primary Health Care; D012307:Risk Factors
D005340:Fibrinogen